3.275
1.36%
-0.045
Finanzdaten der Ovid Therapeutics Inc-Aktie (OVID)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
29.91%
0.1416
|
0.109 | 0.075 | 0.0662 | 0.0889 |
Operating Expenses
|
51.02%
18.33
|
12.14 | 14.25 | 14.96 | 12.22 |
Benefits Costs and Expenses |
36.11%
15.46
|
11.36 | 12.48 | 13.42 | -26.62 |
Costs And Expenses |
36.11%
15.46
|
11.36 | 12.48 | 13.42 | -26.62 |
Operating Income/Loss |
51.21%
-18.19
|
-12.03 | -14.17 | -14.89 | -12.17 |
Income/Loss From Continuing Operations Before Tax |
36.17%
-15.32
|
-11.25 | -12.41 | -13.36 | 26.66 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
36.17%
-15.32
|
-11.25 | -12.41 | -13.36 | 26.66 |
Net Income/Loss
|
36.17%
-15.32
|
-11.25 | -12.41 | -13.36 | -11.50 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.95%
0.0361
|
70.62 | 70.53 | 70.49 | 0.0162 |
Diluted Average Shares |
99.95%
0.0361
|
70.62 | 70.53 | 70.49 | 0.0162 |
Basic Earnings Per Share |
37.50%
-0.22
|
-0.16 | -0.18 | -0.19 | -0.16 |
Diluted Earnings Per Share |
37.50%
-0.22
|
-0.16 | -0.18 | -0.19 | -0.16 |
Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
-
|
- | - | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):